Advertorial

Explore next generation therapeutics and ATMPS in May

Posted: 15 February 2018 | | No comments yet

The 13th annual World Advanced Therapies & Regenerative Medicine Congress brings together 1000+ attendees and explores the rapidly developing world of next generation therapeutics and ATMPS.

14th World Advanced Therapies & Regenerative Medicine Congress 2018

From clinical development to pricing, reimbursement and market access this congress will bring you the most exciting case studies and new data for immunotherapy, cell therapy, gene therapy, CARs and bioprocessing.

Experts in every area will help you tackle the process and regulatory hurdles of developing all new therapeutic formats all the way through manufacture and into the clinic.

In addition, the congress is co-located with the World Precision Medicine Congress, AI in Healthcare Congress and Cord Blood World Europe offering attendees the chance to create their own agenda.

 

Reserve your FREE place

 


Are you advancing promising antibody leads, only to encounter issues with stability, PK or manufacturability later in development?

30 July 2025 | 10:00 AM BST | FREE Webinar

Join us for an expert-led webinar exploring how early-stage developability assessment can help reduce downstream risk and improve candidate selection.

What You’ll Learn:

  • How to identify key developability risks early including aggregation, PK, and manufacturability
  • How to implement high-throughput in vitro assays requiring <1 mg of antibody per test
  • How to combine in silico modeling with wet-lab analytics to guide early optimisation

Don’t miss your chance to learn from Dr Lei Guo.

Register Now – It’s Free!

 

World renowned speakers include:

  • Patrick Soon Shiong, Founder & CEO, NantWorks
  • Margo Roberts, CSO, Kite Pharma
  • Susan Solomon, CEO and Co-Founder, New York Stem Cell Foundation
  • Eric Soller, Vice President of Corporate Development & Strategy, BlueRock Therapeutics
  • Laszlo Radvanyi, Senior Vice President, Senior Scientific Advisor – Immunology, Immuno-Oncology, EMD Serono
  • Jon Wigginton, Chief Medical Officer and Senior Vice-President, Clinical Development, MacroGenics
  • Frédéric Triebel, CSO & CMO, Prima BioMed Ltd
  • Stephen Badylak, Professor, Department of Surgery, Director, Center for Pre-Clinical Tissue Engineering, Deputy Director, McGowan Institute for Regenerative Medicine (MIRM)
  • Keith Thompson, CEO, Cell and Gene Therapy Catapult
  • Xiaobin Victor Lu, CMC Reviewer, CBER, Office of Tissues and Advanced Therapies, Division of Cellular and Gene Therapies, U.S. Food and Drug Administration

The World Advanced Therapy and Regenerative Medicine Congress is two events: A world-class conference where cell, gene and immunotherapy leaders from around the world meet; and a unique life science and healthcare technology exhibition.

The show takes place 16–18 May 2018 at the Business Design Centre in London.

Leave a Reply

Your email address will not be published. Required fields are marked *